Component information
Different name of ingredient
- Lopinavirum
- (αS)-Tetrahydro-N-[(αS)-α-[(2S,3S)-2-hydroxy-4-phenyl-3-[2-(2,6-xylyloxy)acetamido]butyl]phenethyl]-α-isopropyl-2-oxo-1(2H)-pyrimidineacetamide
- ABT-378 (Abbott)
- A 1573780 (Abbott, USA)
- (2S)-N-{(1S,3S,4S)-1-Benzyl-4-[2-(2,6-dimethylphenoxy)acetamido]-3-hydroxy-5-phenylpentyl}-3-methyl-2-(2-oxohexahydropyrimidin-1-yl)butanamid
- Lopinavir
Alternative medicine with selected ingredient
| Name | PZN | Form | Packing | Manufacturer | Price | |
|---|---|---|---|---|---|---|
| Details | KALETRA 200 mg/50 mg Filmtabletten 3 Mon.Pckg. | P14140041 | FTA | 360 St | 101CA | € 2038.53 |
| Details | KALETRA 100 mg/25 mg Filmtabletten | P10232266 | FTA | 60 St | KOHL | € 213.22 |
| Details | LOPINAVIR/Ritonavir Accord 200 mg/50 mg Filmtabl. | P15297678 | FTA | 360 St | ACCOR | € 1888.85 |
| Details | KALETRA 80 mg+20 mg/ml Lösung zum Einnehmen | P13833440 | LSE | 2X60 ml | ABBVI | € 381.10 |
| Details | KALETRA 200 mg/50 mg Filmtabletten 3 Mon.Pckg. | P5461728 | FTA | 360 St | ABBVI | € 2820.22 |
| Details | KALETRA 200 mg/50 mg Filmtabletten 3 Mon.Pckg. | P8931181 | FTA | 360 St | ORI | € 2038.55 |